Kunjin virus replicon vaccine vectors induce protective CD8+ T-cell immunity

Journal of Virology

Volumn 76, Issue 8, 2002, Pages 3791-3799

  Anraku, Itaru ^a   Harvey, Tracey J ^a   Linedale, Richard ^a   Gardner, Joy ^a   Harrich, David ^a   Suhrbier, Andreas ^a   Khromykh, Alexander A ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; DNA VACCINE; MELANOMA ANTIGEN; MELANOMA VACCINE; PLASMID DNA; RNA POLYMERASE II; VIRUS RNA; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER IMMUNIZATION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; ENCAPSULATION; FEMALE; KUNJIN VIRUS; MELANOMA B16; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPLICON; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VACCINIA VIRUS; VIRUS PARTICLE; VIRUS RECOMBINANT;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; FEMALE; GENETIC VECTORS; IMMUNIZATION; MICE; MICE, INBRED BALB C; NEOPLASMS; REPLICON; VACCINIA; VIRAL VACCINES; WEST NILE VIRUS;

EID: 0036196564     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.8.3791-3799.2002     Document Type: Article

References (58)

1. Noncytopathic Sindbis virus RNA vectors for heterologous gene expression
2. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
3. Relevance of the tumor antigen in the validation of three vaccination strategies for melanoma
4. Enhancing immune responses using suicidal DNA vaccines
5. CD91: A receptor for heat shock protein gp96
6. Sindbis virus expression vectors: Packaging of RNA replicons by using defective helper RNAs
7. Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles
8. Peptide based cytotoxic T-cell vaccines; delivery of multiple epitopes, help, memory and problems
9. Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine
10. Self-replicative RNA vaccines elicit protection against influenza A virus, respiratory syncytial virus, and a tickborne encephalitis virus
11. Selection of RNA replicons capable of persistent noncytopathic replication in mammalian cells
12. Natural adjuvants: Endogenous activators of dendritic cells
13. Infection of human dendritic cells by a Sindbis virus replicon vector is determined by a single amino acid substitution in the E2 glycoprotein
14. HIV type 1 vaccine-induced T cell memory and cytotoxic T lymphocyte responses in HIV type 1-uninfected volunteers
15. Loss of dimerisation of the nonstructural protein NS1 of Kunjin virus delays viral replication and reduces virulence in mice, but still allows secretion of NS1
16. DNA immunization against herpes simplex virus: Enhanced efficacy using a Sindbis virusbased vector
17. RNA-RNA recombination in Sindbis virus: Roles of the 3′ conserved motif, poly(A) tail, and nonviral sequences of template RNAs in polymerase recognition and template switching
18. Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production
19. Phenotypic changes in Langerhans' cells after infection with arboviruses: A role in the immune response to epidermally acquired viral infection?
20. Langerhans cells migrate to local lymph nodes following cutaneous infection with an arbovirus
21. Comparison of the protective efficacy of naked DNA, DNA-based Sindbis replicon, and packaged Sindbis replicon vectors expressing Hantavirus structural genes in hamsters
22. Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses
23. Replicon-based vectors of positive strand RNA viruses
24. Subgenomic replicons of the flavivirus Kunjin: Construction and applications
25. trans-complementation of flavivirus RNA polymerase gene NS5 by using Kunjin virus replicon-expressing BHK cells
26. Encapsidation of the flavivirus Kunjin replicon RNA by using a complementation system providing Kunjin virus structural proteins in trans
27. cis- and trans-acting elements in flavivirus RNA replication
28. Coupling between replication and packaging of flavivirus RNA: Evidence derived from the use of DNA-based full-length cDNA clones of Kunjin virus
29. Cytotoxic T cell polyepitope vaccines delivered by ISCOMs
30. Human dendritic cells are activated by dengue virus infection: Enhancement by gamma interferon and implications for disease pathogenesis
31. A new generation of animal cell expression vectors based on the Semliki Forest virus replicon
32. trans-complementation of yellow fever virus NS1 reveals a role in early RNA replication
33. Genetic interaction of flavivirus nonstructural proteins NS1 and NS4A as a determinant of replicase function
34. Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis
35. In vitro-synthesized infectious RNA as an attenuated live vaccine in a flavivirus model
36. Delayed emergence of bovine leukemia virus after vaccination with a protective cytotoxic T cell-based vaccine
37. A recombinant Semliki Forest virus particle vaccine encoding the prME and NS1 proteins of louping ill virus is effective in a sheep challenge model
38. Replicon vectors derived from Sindbis virus and Semliki Forest virus that establish persistent replication in host cells
39. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: Expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo
40. Genesis of Sindbis virus by in vivo recombination of nonreplicative RNA precursors
41. Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity
42. Recombinant viruses as vaccines and immunological tools
43. Recombination between Sindbis virus RNAs
44. Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge
45. Effect of pre-existing cytotoxic T lymphocytes on therapeutic vaccines
46. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen
47. Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination
48. Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes
49. Noncytopathic flavivirus replicon RNA-based system for expression and delivery of heterologous genes
50. Stable high-level expression of heterologous genes in vitro and in vivo by noncytopathic DNA-based Kunjin virus replicon vectors
51. Microparticle-mediated RNA immunization against bovine viral diarrhea virus
52. Naked RNA immunization with replicons derived from poliovirus and Semliki Forest virus genomes for the generation of a cytotoxic T cell response against the influenza A virus nucleoprotein
53. Ultrastructure of Kunjin virus-infected cells: Colocalization of NS1 and NS3 with double-stranded RNA, and of NS2B with NS3, in virus-induced membrane structures
54. Human skin Langerhans cells are targets of dengue virus infection
55. Cancer therapy using a self-replicating RNA vaccine